Loading company…
ProteinQure Inc., founded in 2017 in Toronto, Canada, develops peptide-based drug delivery systems using computational design.
Founded in 2017 and headquartered in Toronto, Canada, ProteinQure Inc. develops peptide-based drug delivery systems. Its ProteinStudio platform uses molecular simulations and custom AI models to design peptides that carry therapeutic payloads into cells. The company was founded by Christopher Ing, Lucas Siow, Mark Fingerhuth and Tomas Babej, and Lucas Siow is CEO. Revenue comes from B2B partnerships with pharmaceutical companies, through development agreements with milestone payments and royalties. In May 2025 it raised USD 11.00 mn in Series A funding from investors including Golden Ventures and Kensington Capital, to support the PQ203 clinical trial.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in